Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Integrin antagonist conjugates for targeted delivery to cells expressing alpha-V-beta-3

Integrin antagonist conjugates for targeted delivery to cells expressing alpha-V-beta-3

US Patent 9586916 · Granted Mar 7, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Inhibitors of receptor interacting protein kinase I for the treatment of disease2025
Dual ATM and DNA-PK inhibitors for use in anti-tumor therapy2025
Isoidide derivatives and methods of making and using same2024
GLS1 inhibitors for treating disease2024
Inhibitors of receptor interacting protein kinase I for the treatment of disease2023
Inhibitors of receptor interacting protein kinase I for the treatment of disease2023
GLS1 inhibitors for treating disease2023
Inhibitors of receptor interacting protein kinase I for the treatment of disease2023
Chitosan covalently linked with small molecule integrin antagonist for targeted 2022
Chitosan covalently linked with small molecule integrin antagonist for targeted 2022
Chitosan covalently linked with small molecule integrin antagonist for targeted 2022
GLS1 inhibitors for treating disease2022